ROMANO, Mario
 Distribuzione geografica
Continente #
NA - Nord America 6.066
EU - Europa 3.866
AS - Asia 3.725
Continente sconosciuto - Info sul continente non disponibili 423
SA - Sud America 367
AF - Africa 74
OC - Oceania 12
AN - Antartide 1
Totale 14.534
Nazione #
US - Stati Uniti d'America 5.903
SG - Singapore 1.441
CN - Cina 927
IT - Italia 809
IE - Irlanda 473
UA - Ucraina 457
GB - Regno Unito 415
SE - Svezia 394
RU - Federazione Russa 383
TR - Turchia 362
FR - Francia 325
VN - Vietnam 317
IN - India 273
BR - Brasile 268
DE - Germania 241
FI - Finlandia 129
BD - Bangladesh 101
HK - Hong Kong 88
CA - Canada 87
PL - Polonia 63
KR - Corea 44
AT - Austria 43
MX - Messico 38
JP - Giappone 36
AR - Argentina 35
NL - Olanda 29
ZA - Sudafrica 28
ES - Italia 27
PE - Perù 19
IQ - Iraq 18
EG - Egitto 17
BE - Belgio 16
PK - Pakistan 15
CZ - Repubblica Ceca 14
PH - Filippine 14
IR - Iran 13
IL - Israele 12
EU - Europa 11
BZ - Belize 10
CL - Cile 10
KE - Kenya 10
LT - Lituania 10
UZ - Uzbekistan 10
VE - Venezuela 10
AU - Australia 9
ID - Indonesia 9
MA - Marocco 9
CO - Colombia 8
SA - Arabia Saudita 8
EC - Ecuador 7
JM - Giamaica 7
AE - Emirati Arabi Uniti 6
PT - Portogallo 5
RO - Romania 5
TW - Taiwan 5
CR - Costa Rica 4
OM - Oman 4
PY - Paraguay 4
SV - El Salvador 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
MY - Malesia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
BS - Bahamas 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BH - Bahrain 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
KI - Kiribati 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
Totale 14.118
Città #
Singapore 1.075
San Jose 688
Chandler 666
Jacksonville 517
Dublin 467
Ashburn 400
Dallas 290
Southend 268
Beijing 229
Council Bluffs 226
Princeton 207
Izmir 202
New York 176
Santa Clara 147
Los Angeles 142
Nanjing 132
Dearborn 112
The Dalles 110
Boardman 108
Chieti 104
Ho Chi Minh City 94
Altamura 90
Wilmington 88
Cambridge 80
Ann Arbor 73
Hanoi 73
Hong Kong 71
Tongling 66
Nanchang 63
Rome 55
Pescara 53
Buffalo 51
Moscow 45
Warsaw 45
Helsinki 37
Montreal 37
Seoul 37
São Paulo 35
Montesilvano 34
Vienna 34
Tokyo 33
Munich 30
Houston 29
San Mateo 29
Phoenix 28
Denver 27
Washington 27
Brooklyn 25
Toronto 25
Chicago 24
Hebei 24
Orem 24
Tianjin 24
Woodbridge 24
Kunming 23
Redondo Beach 23
Dong Ket 22
Johannesburg 22
Shenyang 22
Düsseldorf 21
Jiaxing 21
Falls Church 20
Milan 20
Nuremberg 20
Stockholm 20
Augusta 19
Boston 19
Frankfurt am Main 19
Columbus 18
Hefei 18
Poplar 18
Haiphong 16
London 16
Mexico City 16
San Francisco 16
Brussels 15
Chennai 15
Cornaredo 14
Da Nang 14
Grevenbroich 14
Seattle 14
St Louis 14
Changsha 13
Atlanta 12
Cairo 12
Central 12
Manchester 12
New Delhi 12
Amsterdam 11
Bari 11
Mumbai 11
Turku 11
Ica 10
Nairobi 10
Orange 10
Querétaro 10
San Buono 10
Tashkent 10
Brno 9
Hangzhou 9
Totale 8.504
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 385
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 232
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 218
Establishment and long-term culture of human cystic fibrosis endothelial cells 203
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 203
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 198
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 197
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 197
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 195
Mechanisms of endothelial cell dysfunction in cystic fibrosis 191
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 189
Pentraxin 3 and platelet activation in obese patients after gastric banding 181
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 173
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 168
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 166
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 164
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 162
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 162
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 161
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 160
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 160
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 160
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 159
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 158
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 151
Epigenetic regulation of the formyl peptide receptor 2 gene 150
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 149
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 148
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 148
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 148
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 147
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 146
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 145
Increased soluble CD40L levels in cystic fibrosis 143
Lipoxins, resolvins, and the resolution of inflammation 142
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 141
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 141
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 141
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 140
Leptin increase is associated with markers of the hemostatic system in obese healthy women 138
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 138
Lipoxin receptors 137
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 137
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 136
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 136
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 135
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 133
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 133
Homocysteine modulates the CD40/CD40L system 132
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 132
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 131
A Systematic Review on Organ-on-a-Chip in PDMS or Hydrogel in Dentistry: An Update of the Literature 130
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 130
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 128
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 126
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 124
Lipoxin and aspirin-triggered lipoxins 124
Increased levels of soluble P-selectin in hypercholesterolemic patients 122
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 119
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 119
Transcellular regulation of eicosanoids biosyntesis 117
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 117
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 115
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 115
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 114
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 114
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 113
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 113
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 110
Induction of functional Lipoxin A4 receptors in HL-60 cells 109
Ligand bias and its association with pro-resolving actions of melanocortin drugs 109
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 109
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 108
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 107
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 107
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 107
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip 106
Human alveolar macrophages generate 15-HETE and can produce lipoxins 105
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 105
The Resolution Approach to Cystic Fibrosis Inflammation 104
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 103
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 102
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 101
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 100
Lipoxin synthase activity of human platelet 12-Lipoxygenase 100
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 100
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 100
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 100
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 99
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 99
Inflammation resolution: does the bone marrow have a say? 99
Reduced platelet mitogenic activity in myeloproliferative disorders 97
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 95
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 95
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 95
Loss of CFTR Reverses Senescence Hallmarks in SARS-CoV-2 Infected Bronchial Epithelial Cells 92
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 91
Endothelial perturbation in cystic fibrosis. 91
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 90
Lipoxin generation by permeabilized human platelets 87
Totale 13.602
Categoria #
all - tutte 58.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022577 0 0 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/20252.229 130 381 319 83 81 97 78 118 246 92 267 337
2025/20264.598 321 211 461 560 462 265 763 283 453 413 254 152
2026/2027438 78 237 123 0 0 0 0 0 0 0 0 0
Totale 14.534